Invokana MDL Hearing Set For Dec. 1; Janssen Concurs, Agrees With New Jersey Venue
Defendant Janssen Pharmaceuticals Inc. on Oct. 12 said it agrees with some plaintiffs that at least 57 federal lawsuits alleging kidney failure or ketoacidosis from the diabetes drug should be centralized in an MDL.
(Brief available. Document #28-161020-005B.)
In a response filed with...
To view the full article, register now.